UAMS Researchers Discover Cholesterol Drug's Potential as Treatment for Alzheimer's, Other Dementia
August 07, 2024
August 07, 2024
LITTLE ROCK, Arkansas, Aug. 7 (TNSres) -- The University of Arkansas for Medical Sciences issued the following news release:
Researchers from the University of Arkansas for Medical Sciences (UAMS) have discovered that an FDA-approved cholesterol drug holds the potential to disrupt the progression of Alzheimer's disease and other forms of dementia.
The research team published its findings in the journal Aging Biology. Akshatha Ganne, a postdoctoral fellow in the UAM . . .
Researchers from the University of Arkansas for Medical Sciences (UAMS) have discovered that an FDA-approved cholesterol drug holds the potential to disrupt the progression of Alzheimer's disease and other forms of dementia.
The research team published its findings in the journal Aging Biology. Akshatha Ganne, a postdoctoral fellow in the UAM . . .